{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:46:59Z","timestamp":1783032419504,"version":"3.54.6"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The objective of this study was to evaluate and compare the safety and effectiveness of four different dermal fillers in the treatment of facial lipoatrophy secondary to human immunodeficiency virus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors conducted a clinical trial including 147 patients suffering from human immunodeficiency virus\u2013induced lipoatrophy treated with Sculptra (poly-<jats:sc>l<\/jats:sc>-lactic acid), Radiesse (calcium hydroxylapatite), Aquamid (polyacrylamide), or autologous fat. Objective and subjective changes were evaluated during a 24-month follow-up. Number of sessions, total volume injected, and overall costs of treatment were also analyzed. A comparative cost-effectiveness analysis of the treatment options was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Objective improvement in facial lipoatrophy, assessed by the surgeon in terms of changes from baseline using the published classification of Fontdevila, was reported in 53 percent of the cases. Patient self-evaluation showed a general improvement after the use of facial fillers. Patients reported being satisfied with the treatment and with the reduced impact of lipodystrophy on their quality of life. Despite the nonsignificant differences observed in the number of sessions and volume, autologous fat showed significantly lower costs than all synthetic fillers (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Surgical treatment of human immunodeficiency virus\u2013associated facial lipoatrophy using dermal fillers is a safe and effective procedure that improves the aesthetic appearance and the quality of life of patients. Permanent fillers and autologous fat achieve the most consistent results over time, with lipofilling being the most cost-effective procedure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000004173","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T21:15:47Z","timestamp":1510780547000},"page":"613-623","source":"Crossref","is-referenced-by-count":13,"title":["Comparing Efficacy and Costs of Four Facial Fillers in Human Immunodeficiency Virus\u2013Associated Lipodystrophy: A Clinical Trial"],"prefix":"10.1097","volume":"141","author":[{"given":"Alfonso","family":"Vallejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela A.","family":"Garcia-Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Deleyto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Perez-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230715","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sti.79.2.137","article-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals.","volume":"79","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R2-20230715","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"issue":"Suppl 3","key":"R3-20230715","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00126334-200212153-00011","article-title":"Relationship between HAART adherence and adipose tissue alterations.","volume":"31","author":"Ammassari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-20230715","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1055329003255117","article-title":"HIV lipodystrophy syndrome: A primer.","volume":"15","author":"Robinson","year":"2004","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R5-20230715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001432-200402000-00005","article-title":"What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.","volume":"17","author":"Tien","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"R6-20230715","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.anplas.2011.11.005","article-title":"Treatment of facial lipoatrophy by lipofilling in HIV infected patients: Retrospective study on 317 patients on 9 years (in French).","volume":"57","author":"Uzzan","year":"2012","journal-title":"Ann Chir Plast Esthet"},{"key":"R7-20230715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0b013e32833f1463","article-title":"Surgical correction of HIV-associated facial lipoatrophy.","volume":"25","author":"Guaraldi","year":"2011","journal-title":"AIDS"},{"issue":"Suppl 2","key":"R8-20230715","first-page":"L31","article-title":"Validation of a simple classification for facial lipoatrophy in HIV-infected adults.","volume":"12","author":"Fontdevila","year":"2007","journal-title":"Antiviral Ther"},{"key":"R9-20230715","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00453875","article-title":"Long-term survival of fat transplants: Controlled demonstrations.","volume":"19","author":"Coleman","year":"1995","journal-title":"Aesthetic Plast Surg"},{"key":"R10-20230715","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0094-1298(20)31069-5","article-title":"Facial recontouring with lipostructure.","volume":"24","author":"Coleman","year":"1997","journal-title":"Clin Plast Surg"},{"key":"R11-20230715","first-page":"692","article-title":"Adaptaci\u00f3n transcultural al espa\u00f1ol del cuestionario Dermatology Life Quality Index (DLQI): El \u00cdndice de Calidad de Vida en Dermatolog\u00eda.","volume":"89","author":"De Tiedra","year":"1998","journal-title":"Actas Dermosifiliogr"},{"key":"R12-20230715","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/ijd.12400","article-title":"Treatment of facial lipoatrophy with polymethylmethacrylate among patients with human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDS): Impact on the quality of life.","volume":"53","author":"Quintas","year":"2014","journal-title":"Int J Dermatol"},{"key":"R13-20230715","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1086\/383573","article-title":"Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1.","volume":"38","author":"Blanch","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R14-20230715","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00126334-200212010-00006","article-title":"Impact of lipodystrophy on the quality of life of HIV-1-infected patients.","volume":"31","author":"Blanch","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl","key":"R15-20230715","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1097\/01.prs.0000234847.36020.52","article-title":"Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: One-year durability.","volume":"118","author":"Silvers","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"R16-20230715","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R17-20230715","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PRS.0b013e3182362142","article-title":"Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: A 5-year follow-up.","volume":"129","author":"De Santis","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R18-20230715","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/SCS.0b013e31822e5cf8","article-title":"Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.","volume":"22","author":"Rauso","year":"2011","journal-title":"J Craniofac Surg"},{"key":"R19-20230715","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/QAD.0b013e3282f56b40","article-title":"Differential gene expression indicates that \u2018buffalo hump\u2019 is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.","volume":"22","author":"Guallar","year":"2008","journal-title":"AIDS"},{"key":"R20-20230715","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000148252","article-title":"Hyaluronic acid new formulation: Experience in HIV-associated facial lipoatrophy.","volume":"217","author":"Bechara","year":"2008","journal-title":"Dermatology"},{"key":"R21-20230715","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/01.prs.0000267341.14550.a7","article-title":"Surgical algorithm for management of HIV lipodystrophy.","volume":"120","author":"Davison","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R22-20230715","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA.","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006534-201803000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T05:30:03Z","timestamp":1689399003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006534-201803000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000004173","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}